Filing Details
- Accession Number:
- 0000921895-22-002509
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-22 16:08:10
- Reporting Period:
- 2022-08-18
- Accepted Time:
- 2022-08-22 16:08:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1123494 | Harvard Bioscience Inc | HBIO | Laboratory Analytical Instruments (3826) | 043306140 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197452 | Bertrand Loy | C/O Harvard Bioscience, Inc. 84 October Hill Rd. Holliston MA 01746 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-08-18 | 1,151 | $3.19 | 341,360 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-08-19 | 9,608 | $3.28 | 350,968 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 68,466 | Indirect | by The BZH Trust |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $3.175 to $3.20, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- Includes (a) the shares purchased in the transaction described in footnote (1) above, (b) 47,493 restricted stock units that will vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders, immediately prior to the commencement of such meeting, and (ii) May 24, 2023, and (c) 292,716 shares of common stock held by the Reporting Person.
- This transaction was executed in multiple trades at prices ranging from $3.24 to $3.30, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- Includes (a) the shares described in footnote (2) above and (b) the shares purchased in the transaction described in footnote (3) above.
Billionaire Hedge Funds
